Publication
Long-term outcomes of tricuspid valve replacement in the current era.
Farzan Filsoufi MD, Ani C. Anyanwu MD, Sacha P. Salzberg MD, Tim Frankel MD, Lawrence H. Cohn MD and David H. Adams MD
Regardless of the indication, tricuspid valve replacement (TVR) has historically been associated with high mortality and morbidity. We report the results of our experience in a high-risk patient population with an emphasis on operative mortality, long-term survival, and valve related events according to the type of prosthesis.
Page Created: January 08, 2018
Last Updated: January 08, 2018
Share
Publications
-
Aortic Arch Replacement: How I Teach It
Amine Mazine, Nitish K Dhingra, Michael W A Chu, Ismail El-Hamamsy, Mark D Peterson -
Mitral Annular Disjunction: A Contrary View
Dimosthenis Pandis, MD, MSc, Anelechi C. Anyanwu, MD, FRCS, David H. Adams, MD, FACC -
Direct access hybrid transatrial implantation of a Sapien 3 valve inside a bioprosthetic mitral valve with concomitant tricuspid valve replacement and cryoablation
Sophia L. Alexis, Gilbert H. L. Tang, Dimosthenis Pandis, David H. Adams, Ahmed El-Eshmawi -
The Ross procedure: total root technique
Elbert E Williams, Ismail El-Hamamsy